Study Summary
This study is evaluating whether a new treatment approach may help patients with advanced pancreatic cancer.
Eligible Conditions
- Pancreatic Cancer
Treatment Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 36 months
36 months
Number of participants assigned therapy with OncoTreat
Trial Safety
Trial Design
2 Treatment Groups
Observation Arm
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment
30 Total Participants · 2 Treatment Groups
Primary Treatment: OncoTreat · No Placebo Group · N/A
Intervention Arm
Device
Experimental Group · 1 Intervention: OncoTreat · Intervention Types: DeviceObservation ArmNoIntervention Group · 1 Intervention: Observation Arm · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 36 months
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,295 Previous Clinical Trials
1,613,241 Total Patients Enrolled
Rachael A. Safyan, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
31 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments